CAS 252916-29-3: Orantinib
Description:Orantinib, with the CAS number 252916-29-3, is a small molecule that functions primarily as a tyrosine kinase inhibitor. It is designed to target specific pathways involved in tumor growth and angiogenesis, making it a candidate for cancer treatment. The compound exhibits a unique chemical structure that allows it to interact with various kinases, thereby inhibiting their activity and potentially slowing down the progression of certain cancers. Orantinib has shown promise in preclinical studies and clinical trials, particularly in the context of solid tumors. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile. Additionally, like many targeted therapies, it may have a range of side effects, which necessitates careful monitoring during treatment. Overall, Orantinib represents a significant advancement in the development of targeted cancer therapies, reflecting ongoing research efforts in the field of oncology.
Formula:C18H18N2O3
InChI:InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)
InChI key:InChIKey=NHFDRBXTEDBWCZ-UHFFFAOYSA-N
SMILES:O=C(O)CCC1=C(NC(C=C2C(=O)NC=3C=CC=CC32)=C1C)C
- Synonyms:
- 1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 3-[2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid
- 3-[2,4-Dimethyl-5-[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propionic acid
- 3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
- 3-[4-(2-Carboxyethyl)-3,5-dimethylpyrrol-2-methylidenyl]-2-indolinone
- 3-{2,4-dimethyl-5-[(E)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
- 5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid
- NSC 702827
- Orantinib
- Su-6668
- See more synonyms
- Tsu-68